文献速递乳腺MR

降低BI-RADS 4类乳腺病变活检率:简化式先进DWI方案的潜力

Reduction of biopsy rate in BI-RADS4 breast lesions: potential of an abbreviated advanced DWI protocol.
PubMed 文献 · Eur Radiol · 2025-04-24

回顾性分析2019至2023年168例女性178个DCE-MRI检出的BI-RADS 4类乳腺病变,比较简化DWI方案衍生的扩散生物标志物(ADC0-800、IVIM灌注分数、ADC0、峰度K、S-index、sADC)的诊断效能及减少不必要活检的潜力。各参数AUC为0.66–0.69,应用阈值后均可减少约16%的不必要活检,K的减少率略高于ADC0-800(20.5% vs 15.9%,p=0.317)且未降低敏感度。

要点

  • 简化DWI方案(b值0、200、800、1500 s/mm²)衍生的扩散生物标志物对BI-RADS 4类乳腺病变的鉴别效能与ADC相当(AUC 0.66–0.69)。
  • 应用阈值后各参数均可减少约16%的不必要活检;K减少率20.5%略高于ADC0-800的15.9%(p=0.317),且未降低敏感度。
  • 恶性病变ADC0-800、sADC、ADC0中位值显著低于良性,S-index与K显著高于良性(均p≤0.001)。

核心结论

  • 简化DWI方案获得的扩散MRI生物标志物可减少BI-RADS 4类乳腺病变的不必要活检,K的表现略优于ADC。

研究设计与样本

  • 回顾性研究,2019至2023年,168例女性患者(平均年龄56.2±13.5岁)的178个DCE-MRI检出的BI-RADS 4类乳腺病变,均在3 T下行简化DWI(b值0、200、800、1500 s/mm²),手动放置感兴趣区估算ADC0-800、IVIM灌注分数、ADC0、峰度K、S-index与sADC。

关键影像表现/征象

  • 恶性病变的ADC0-800、sADC、ADC0中位值显著低于良性病变(均p≤0.001)。
  • 恶性病变的S-index与K显著高于良性病变(均p≤0.001)。

诊断标准与关键数值

  • ADC0-800鉴别良恶性的AUC为0.67。
  • sADC的AUC为0.69,S-index的AUC为0.69。
  • ADC0的AUC为0.68,K的AUC为0.66。
  • 应用ad-hoc阈值后各参数减少不必要活检约16%,K减少20.5% vs ADC0-800减少15.9%(p=0.317)。

临床应用与阅片要点

  • 对DCE-MRI检出的BI-RADS 4类病变,可参考简化DWI衍生的扩散生物标志物辅助判断良恶性。
  • 各参数鉴别效能与ADC相当,K在减少不必要活检方面表现略优于ADC0-800且未降低敏感度。
  • 作者认为这些生物标志物可能有助于改善患者管理决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study compared the diagnostic performance of diffusion biomarkers estimated from an abbreviated diffusion-weighted imaging (DWI) protocol and assessed their potential to reduce unnecessary biopsies of benign BI-RADS 4 lesions identified on dynamic contrast-enhanced (DCE) MRI.

METHODS: A retrospective study was conducted from 2019 to 2023. All patients underwent abbreviated DWI at 3 T with four b-values (0 s/mm2, 200 s/mm2, 800 s/mm2, and 1500 s/mm2). Regions of interest were manually placed on DWI, and biomarkers, including the apparent diffusion coefficient (ADC0-800), perfusion fraction intravoxel incoherent motion, non-Gaussian diffusion (ADC0 and kurtosis [K]), signature index (S-index), and shifted ADC (sADC), were estimated. Diagnostic performance and the potential to reduce unnecessary biopsies were evaluated for each parameter.

RESULTS: In total, 168 female patients (mean age ± standard deviation, 56.2 ± 13.5 years) with 178 BI-RADS 4 lesions on DCE MRI were analyzed. The median ADC0-800, sADC, and ADC0 were significantly lower in malignant lesions, while S-index and K were significantly higher (all p ≤ 0.001). The diagnostic performance to reclassify lesions as benign or malignant was identical for ADC0-800 (area under the curve = 0.67), sADC (0.69), S-index (0.69), ADC0 (0.68), and K (0.66). Applying an ad-hoc threshold cutoff, all parameters reduced unnecessary biopsies (around 16%), while K resulted in a slightly higher reduction rate than ADC0-800 (20.5% vs 15.9%, p = 0.317) without reducing sensitivity.

CONCLUSION: Diffusion MRI biomarkers obtained using an abbreviated DWI protocol reduced unnecessary biopsies in BI-RADS 4 lesions, with K performing slightly better than ADC.

KEY POINTS: Question MRI BI-RADS category 4 includes a substantial number of benign lesions, and reducing unnecessary biopsies remains a critical clinical concern. Findings The parameters from abbreviated DWI show lesion differentiation comparable to ADC and have greater potential to reduce unnecessary biopsies. Clinical relevance This study underscores the potential of imaging biomarkers from abbreviated DWI for assessing breast MRI BI-RADS 4 lesions. These biomarkers may be comparable or superior to standard ADC in reducing unnecessary biopsies and could aid in improving patient management decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Goto M, Le Bihan D, Sakai K, et al. Reduction of biopsy rate in BI-RADS4 breast lesions: potential of an abbreviated advanced DWI protocol. Eur Radiol. 2025. PMID: 40272489. doi:10.1007/s00330-025-11604-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。